- Home
- STVN vs PDI Comparison
STVN vs PDI Comparison
Compare STVN & PDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STVN
- PDI
- Stock Information
- Founded
- STVN 1949
- PDI 2012
- Country
- STVN Italy
- PDI United States
- Employees
- STVN N/A
- PDI N/A
- Industry
- STVN Containers/Packaging
- PDI Trusts Except Educational Religious and Charitable
- Sector
- STVN Consumer Discretionary
- PDI Finance
- Exchange
- STVN Nasdaq
- PDI Nasdaq
- Market Cap
- STVN 5.7B
- PDI N/A
- IPO Year
- STVN 2021
- PDI N/A
- Fundamental
- Price
- STVN $20.93
- PDI $19.86
- Analyst Decision
- STVN Buy
- PDI
- Analyst Count
- STVN 7
- PDI 0
- Target Price
- STVN $26.93
- PDI N/A
- AVG Volume (30 Days)
- STVN 372.3K
- PDI 1.5M
- Earning Date
- STVN 03-06-2025
- PDI 01-01-0001
- Dividend Yield
- STVN 0.28%
- PDI 13.81%
- EPS Growth
- STVN N/A
- PDI N/A
- EPS
- STVN 0.45
- PDI N/A
- Revenue
- STVN $1,143,012,735.00
- PDI N/A
- Revenue This Year
- STVN $8.60
- PDI N/A
- Revenue Next Year
- STVN $12.43
- PDI N/A
- P/E Ratio
- STVN $46.99
- PDI N/A
- Revenue Growth
- STVN 1.72
- PDI N/A
- 52 Week Low
- STVN $16.56
- PDI $15.45
- 52 Week High
- STVN $31.61
- PDI $19.60
- Technical
- Relative Strength Index (RSI)
- STVN 50.35
- PDI 56.14
- Support Level
- STVN $20.11
- PDI $19.56
- Resistance Level
- STVN $21.21
- PDI $19.96
- Average True Range (ATR)
- STVN 1.00
- PDI 0.17
- MACD
- STVN -0.05
- PDI -0.01
- Stochastic Oscillator
- STVN 35.51
- PDI 80.56
About STVN Stevanato Group S.p.A.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.